From Predictions to Reality: Mike Stenberg Assesses Pharma Manufacturing's First Half of 2026
AI Briefing
- • Mike Stenberg assesses pharma manufacturing's performance in the first half of 2026, citing various trends and predictions.
- • He notes that supply chain disruptions continue to impact the industry, affecting production and distribution.
- • Stenberg also highlights advancements in digitalization and automation, driving efficiency and innovation in pharma manufacturing.
Advertisement